Michael G. Schlossmacher

Neurology

75 Francis St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Journal: Journal of Parkinson's disease

Published: October 03, 2025

The Parkinson's disease-linked G2019S mutation of LRRK2 increases NADPH oxidase-2 activity in neutrophils for superior control of bacterial infections.

The Parkinson's disease-linked G2019S mutation of LRRK2 increases NADPH oxidase-2 activity in neutrophils for superior control of bacterial infections.

Journal: Cellular & molecular immunology

Published: October 01, 2025

Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease.

Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 16, 2025

Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial Datasets.

Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial Datasets.

Journal: Neurology

Published: December 06, 2024

Variants in Lrrk2 and Snca deficiency do not alter the course of primary encephalitis due to neurotropic reovirus T3D in newborn mice.

Variants in Lrrk2 and Snca deficiency do not alter the course of primary encephalitis due to neurotropic reovirus T3D in newborn mice.

Journal: PloS one

Published: October 21, 2024

Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.

Development of a simplified smell test to identify Parkinson's disease using multiple cohorts, machine learning and item response theory.

Journal: NPJ Parkinson's disease

Published: October 08, 2024

Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.

Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort.

Journal: Journal of Parkinson's disease

Published: September 20, 2024

Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Journal: Acta neuropathologica communications

Published: September 18, 2024

Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.

Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.

Journal: Nature reviews. Neurology

Published: September 09, 2024

Race and ethnicity matter! Moving Parkinson's risk research towards diversity and inclusiveness.

Race and ethnicity matter! Moving Parkinson's risk research towards diversity and inclusiveness.

Journal: NPJ Parkinson's disease

Published: February 29, 2024

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.

Journal: Acta neuropathologica communications

Published: December 19, 2023

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy.

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy.

Journal: Cell death & disease

Published: July 18, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026